Chronic Hepatitis B and COVID-19 Clinical Outcomes in the United States: A Multisite Retrospective Cohort Study
Chronic HBV was associated with worse SARS-CoV-2 outcomes, whereas SARS-CoV-2 vaccination reduced the likelihood of adverse outcomes.
Authors
- George A. Yendewa (ORCID: https://orcid.org/0000-0002-8474-1812)
- Temitope Olasehinde (ORCID: https://orcid.org/0009-0002-3924-7847)
- Robert A. Salata (ORCID: https://orcid.org/0000-0001-8464-0918)
- Amir M. Mohareb
- Frank Mulindwa (ORCID: https://orcid.org/0000-0003-4831-1185)
- Jeffrey M. Jacobson (ORCID: https://orcid.org/0000-0003-0725-249X)
Institutions
- Harvard University (US)
- University Hospitals of Cleveland (US)
- Massachusetts General Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- United Health Services (US)
- Center for Global Health (US)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1093/ofid/ofaf013
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Norges Idrettshøgskole
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases